Eli Lilly files six lawsuits over black-market retatrutide sales
Eli Lilly filed six new lawsuits against U.S. companies allegedly selling black-market versions of its investigational weight-loss drug retatrutide, which remains in Phase 3 clinical trials and has not been approved by any regulator for human use. The company also referred hundreds of bad actors to regulators and law enforcement worldwide.
Detected & updated continuously · Source: Nebula
Story subjects
Sources
@himshouse
🚨 BREAKING: Eli Lilly files six new lawsuits against U.S. companies selling "black-market" retatrutide And referred hundreds of bad actors to regulators and law enforcement worldwide $LLY $NVO $HIMS https://t.co/vW9nYiElVy
@qz
Eli Lilly is suing six companies over illegal sales of its unapproved weight loss drug: The drug remains in Phase 3 clinical trials and has not been approved by any regulator for human use https://t.co/iJztfF73Kv https://t.co/4dyrppItnl
@WSJ
Eli Lilly has filed six new lawsuits against U.S. entities that it alleges are selling a version of the company’s investigational weight-loss drug on the black market. https://t.co/MxDJc18cju